Krasowski Dental Introduces New Sleep Apnea Device

The SomnoMed G2 lingual-less oral appliance has received clearance from the FDA.

Krasowski Dental is now utilizing the SomnoMed G2 lingual-less oral appliance for almost all its sleep apnea treatment. This new treatment was cleared by the FDA on May 30, 2012 (510(k) No: K121340), and contains all the features necessary for reimbursement by Medicare.

No votes yet

Ventus Reports Favorable Results in Snoring Treatment Trial

According to the company’s clinical trial data, Theravent has shown positive results in reducing the volume and duration of snoring in patients.

Ventus Medical announces the publication of clinical trial data for its new Theravent Advanced Nightly Snore Therapy in Sleep Diagnosis and Therapy, a medical journal for sleep professionals.

No votes yet

Data Backs Gender-specific Dosing of Insomnia Drug

A report presented at a recent American Psychiatric Assn. meeting supports gender-specific dozing of Intermezzo sublingual sleep-aid tablets.

The new prescription sleep aid Intermezzo (zolpidem tartrate) sublingual tablet CIV is the first and only prescription sleep aid approved by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep, and the patient has at least four hours of bedtime remaining before the planned time of waking.

Your rating: None Average: 5 (1 vote)
Syndicate content